Peak Financial Advisors’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-13,816
Closed -$2.39M 88
2021
Q4
$2.39M Buy
13,816
+1,202
+10% +$183K 1.84% 20
2021
Q3
$1.83M Buy
+12,614
New +$1.85M 1.61% 25

Other funds holding DGX

Peak Financial Advisors's DGX Position: Q1 2022 in Review

Peak Financial Advisors sold out of Quest Diagnostics (DGX) in Q1 2022, closing a stake of 13,816 shares — an estimated $2.39M sold.

Peak Financial Advisors first reported a position in DGX in Q3 2021 and held it in 2 quarters. The position peaked at $2.39M in Q4 2021. 852 funds tracked by Wall St. Rank hold DGX as of Q1 2022.

  • Peak Financial Advisors reported no remaining Quest Diagnostics position as of Q1 2022 after selling out during the quarter.
  • Peak Financial Advisors sold 13,816 Quest Diagnostics shares in Q1 2022, an estimated $2.39M.
  • Peak Financial Advisors first reported a position in Quest Diagnostics in Q3 2021 and held it in 2 quarters.
  • Peak Financial Advisors's Quest Diagnostics position peaked at $2.39M in Q4 2021.
  • 852 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2022.

Based on Peak Financial Advisors's 13F filing for Q1 2022, filed 22 Apr 2022.